Cargando…

Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients

OBJECTIVES: There is a general lack of effective and non-toxic chemotherapeutic agents for leishmaniasis and there is as yet no study about the effect of HIV peptidase inhibitors (HIV PIs) on Leishmania/HIV-coinfected patients. In the present work, we performed a comparative analysis of the spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Lívia O., Vitório, Bianca S., Branquinha, Marta H., Pedroso e Silva, Conceição M., Santos, André L. S., d'Avila-Levy, Claudia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543121/ https://www.ncbi.nlm.nih.gov/pubmed/23109184 http://dx.doi.org/10.1093/jac/dks410

Ejemplares similares

HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis
por: Santos, Lívia O., et al.
Publicado: (2009)

Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy
por: Santos, L.O., et al.
Publicado: (2013)

Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Trypanosoma cruzi and Inhibit Both Aspartyl-Type Peptidase and Cruzipain Activities Detected in These Crucial Organelles
por: Sangenito, Leandro S., et al.
Publicado: (2021)

Calpains of Leishmania braziliensis: genome analysis, differential expression, and functional analysis
por: Ennes-Vidal, Vítor, et al.
Publicado: (2019)

Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes
por: Rebello, Karina M., et al.
Publicado: (2018)

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors
por: Sangenito, Leandro Stefano, et al.
Publicado: (2022)

Therapeutic Strategies against Leishmania and Trypanosoma
por: Santos, André L. S., et al.
Publicado: (2023)

Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase
por: Castilho, Vanessa V. S., et al.
Publicado: (2018)

Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model
por: Sangenito, Leandro S., et al.
Publicado: (2014)

Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors
por: Palmeira, Vanila F., et al.
Publicado: (2018)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

Antileishmanial activity of MDL 28170, a potent calpain inhibitor
por: d’Avila-Levy, Claudia M., et al.
Publicado: (2006)

Expression of calpain-like proteins and effects of calpain inhibitors on the growth rate of Angomonas deanei wild type and aposymbiotic strains
por: de Oliveira, Simone Santiago Carvalho, et al.
Publicado: (2015)

Susceptibility of Phytomonas serpens to calpain inhibitors in vitro: interference on the proliferation, ultrastructure, cysteine peptidase expression and interaction with the invertebrate host
por: de Oliveira, Simone Santiago Carvalho, et al.
Publicado: (2016)

Differences in Charge Distribution in Leishmania tarentolae Leishmanolysin Result in a Reduced Enzymatic Activity
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)

Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction
por: Granato, Marcela Q., et al.
Publicado: (2020)

The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds
por: Oliveira, Simone S. C., et al.
Publicado: (2023)

Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015)

Nelfinavir, an HIV-1 Protease Inhibitor, Induces Oxidative Stress–Mediated, Caspase-Independent Apoptosis in Leishmania Amastigotes
por: Kumar, Pranav, et al.
Publicado: (2010)

The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?
por: Ennes-Vidal, Vítor, et al.
Publicado: (2021)

Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)

Chagas Disease Control—Many Approaches to Prospect
por: Branquinha, Marta H., et al.
Publicado: (2023)

Induction of Suicidal Erythrocyte Death by Nelfinavir
por: Bissinger, Rosi, et al.
Publicado: (2015)

The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes
por: Marinho, Fernanda A., et al.
Publicado: (2014)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
por: Besse, Lenka, et al.
Publicado: (2023)

Studies on the CPA cysteine peptidase in the Leishmania infantum genome strain JPCM5
por: Denise, Hubert, et al.
Publicado: (2006)

Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)

MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011)

Analysis of Peptidases in Non-Infected and Trypanosoma cruzi-Infected Mouse Embryo Hepatocyte Cells
por: de Melo, Ana Cristina Nogueira, et al.
Publicado: (2008)

HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in Fonsecaea pedrosoi
por: Palmeira, Vanila F., et al.
Publicado: (2017)

Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir
por: Cheng, Wen-Hsin, et al.
Publicado: (2015)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Novel pseudo-aspartic peptidase from the midgut of the tick Rhipicephalus microplus
por: Lu, S., et al.
Publicado: (2019)

Why calpain inhibitors are interesting leading compounds to search for new therapeutic options to treat leishmaniasis?
por: ENNES-VIDAL, VITOR, et al.
Publicado: (2017)

Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgut
por: Verma, Sudha, et al.
Publicado: (2017)

Partial Characterization of Two Cathepsin D Family Aspartic Peptidases of Clonorchis sinensis
por: Kang, Jung-Mi, et al.
Publicado: (2019)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
por: Brüning, Ansgar, et al.
Publicado: (2010)

New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
por: Antunes, Dinler A., et al.
Publicado: (2014)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
por: Resino, Salvador, et al.
Publicado: (2006)

A Stroll Through the History of Monoxenous Trypanosomatids Infection in Vertebrate Hosts
por: Boucinha, Carolina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ot1gmlfma3ra01osrjnjneboe9